Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.

Mancuso M, Arnold M, Bersano A, Burlina A, Chabriat H, Debette S, Enzinger C, Federico A, Filla A, Finsterer J, Hunt D, Lesnik Oberstein S, Tournier-Lasserve E, Markus HS.

Eur J Neurol. 2020 Mar 20. doi: 10.1111/ene.14183. [Epub ahead of print]

PMID:
32196841
2.

Early Progressive Changes in White Matter Integrity Are Associated with Stroke Recovery.

Pinter D, Gattringer T, Fandler-Höfler S, Kneihsl M, Eppinger S, Deutschmann H, Pichler A, Poltrum B, Reishofer G, Ropele S, Schmidt R, Enzinger C.

Transl Stroke Res. 2020 Mar 4. doi: 10.1007/s12975-020-00797-x. [Epub ahead of print]

PMID:
32130685
3.

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies.

Hochmeister S, Gattringer T, Asslaber M, Stangl V, Haindl MT, Enzinger C, Höftberger R.

Front Neurol. 2020 Feb 14;11:31. doi: 10.3389/fneur.2020.00031. eCollection 2020.

4.

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.

Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, Río J, Frederiksen J, Palace J, Vrenken H, Montalban X, Rovira À; MAGNIMS study group.

Nat Rev Neurol. 2020 Mar;16(3):171-182. doi: 10.1038/s41582-020-0314-x. Epub 2020 Feb 24. Review.

5.

Ventilation time and prognosis after stroke thrombectomy: the shorter, the better!

Fandler-Höfler S, Heschl S, Kneihsl M, Argüelles-Delgado P, Niederkorn K, Pichler A, Deutschmann H, Fazekas F, Berghold A, Enzinger C, Gattringer T.

Eur J Neurol. 2020 Feb 17. doi: 10.1111/ene.14178. [Epub ahead of print]

PMID:
32065457
6.

Serum neurofilament light levels in normal aging and their association with morphologic brain changes.

Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, Benkert P, Ropele S, Enzinger C, Fazekas F, Schmidt R, Kuhle J.

Nat Commun. 2020 Feb 10;11(1):812. doi: 10.1038/s41467-020-14612-6.

7.

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis.

Geraldes R, Juryńczyk M, Dos Passos G, Prichler A, Chung K, Hagens M, Ruggieri S, Huerga E, Sastre-Garriga J, Enzinger C, Chard DT, Barkhof F, Gasperini C, Rovira A, DeLuca GC, Palace J; MAGNIMS study group.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):388-391. doi: 10.1136/jnnp-2019-322369. Epub 2020 Feb 7.

PMID:
32034114
8.

Mean Platelet Volume Does Not Predict Restenosis After Carotid Artery Stenting in Whites.

Haidegger M, Kneihsl M, Niederkorn K, Deutschmann H, Augustin M, Wünsch G, Fandler-Höfler S, Horner S, Fazekas F, Enzinger C, Gattringer T.

Stroke. 2020 Mar;51(3):986-989. doi: 10.1161/STROKEAHA.119.028180. Epub 2019 Dec 18.

PMID:
31847751
9.

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis.

Wottschel V, Chard DT, Enzinger C, Filippi M, Frederiksen JL, Gasperini C, Giorgio A, Rocca MA, Rovira A, De Stefano N, Tintoré M, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group and the EuroPOND consortium.

Neuroimage Clin. 2019;24:102011. doi: 10.1016/j.nicl.2019.102011. Epub 2019 Oct 22.

10.

Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis.

Ekker MS, Jacob MA, van Dongen MM, Aarnio K, Annamalai AK, Arauz A, Arnold M, Barboza MA, Bolognese M, Brouns R, Chuluun B, Chuluunbaatar E, Dagvajantsan B, Debette S, Don A, Enzinger C, Ekizoglu E, Fandler-Höfler S, Fazekas F, Fromm A, Gattringer T, Gulli G, Hoffmann M, Hora TF, Jern C, Jood K, Kamouchi M, Kim YS, Kitazono T, Kittner SJ, Kleinig TJ, Klijn CJM, Korv J, Lee TH, Leys D, Maaijwee NA, Martinez-Majander N, Marto JP, Mehndiratta MM, Mifsud V, Montanaro VV, Owolabi MO, Patel VB, Phillips MC, Piechowski-Iozwiak B, Pikula A, Ruiz-Sandoval JL, Sarnowski B, Schreuder FH, Swartz RH, Tan KS, Tanne D, Tatlisumak T, Thijs V, Tuladhar AM, Viana-Baptista M, Vibo R, Wu TY, Yesilot N, Waje-Andreassen U, Pezzini A, Putaala J, de Leeuw FE.

BMJ Open. 2019 Nov 14;9(11):e031144. doi: 10.1136/bmjopen-2019-031144.

11.

Predictors of Lesion Cavitation After Recent Small Subcortical Stroke.

Gattringer T, Valdes Hernandez M, Heye A, Armitage PA, Makin S, Chappell F, Pinter D, Doubal F, Enzinger C, Fazekas F, Wardlaw JM.

Transl Stroke Res. 2019 Nov 8. doi: 10.1007/s12975-019-00741-8. [Epub ahead of print]

PMID:
31705427
12.

Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function.

Pinter D, Beckmann CF, Fazekas F, Khalil M, Pichler A, Gattringer T, Ropele S, Fuchs S, Enzinger C.

Sci Rep. 2019 Nov 7;9(1):16221. doi: 10.1038/s41598-019-52757-7.

13.

Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods.

de Sitter A, Visser M, Brouwer I, Cover KS, van Schijndel RA, Eijgelaar RS, Müller DMJ, Ropele S, Kappos L, Rovira Á, Filippi M, Enzinger C, Frederiksen J, Ciccarelli O, Guttmann CRG, Wattjes MP, Witte MG, de Witt Hamer PC, Barkhof F, Vrenken H; MAGNIMS Study Group and Alzheimer’s Disease Neuroimaging Initiative.

Eur Radiol. 2020 Feb;30(2):1062-1074. doi: 10.1007/s00330-019-06459-3. Epub 2019 Nov 5.

14.

Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke.

Fandler-Höfler S, Enzinger C, Kneihsl M, Pinter D, Eppinger S, Obermayer-Pietsch B, Goritschan A, Hafner-Giessauf H, Rosenkranz AR, Fazekas F, Gattringer T.

Sci Rep. 2019 Oct 28;9(1):15410. doi: 10.1038/s41598-019-51965-5.

15.

Total gray matter volume is reduced in individuals with bipolar disorder currently treated with atypical antipsychotics.

Birner A, Bengesser SA, Seiler S, Dalkner N, Queissner R, Platzer M, Fellendorf FT, Hamm C, Maget A, Pilz R, Lenger M, Reininghaus B, Pirpamer L, Ropele S, Hinteregger N, Magyar M, Deutschmann H, Enzinger C, Kapfhammer HP, Reininghaus EZ.

J Affect Disord. 2020 Jan 1;260:722-727. doi: 10.1016/j.jad.2019.09.068. Epub 2019 Sep 19.

PMID:
31563071
16.

Self-regulation of brain activity and its effect on cognitive function in patients with multiple sclerosis - First insights from an interventional study using neurofeedback.

Kober SE, Pinter D, Enzinger C, Damulina A, Duckstein H, Fuchs S, Neuper C, Wood G.

Clin Neurophysiol. 2019 Nov;130(11):2124-2131. doi: 10.1016/j.clinph.2019.08.025. Epub 2019 Sep 7.

PMID:
31546180
17.

[Use of smartphone apps in secondary stroke prevention].

Fruhwirth V, Enzinger C, Weiss E, Schwerdtfeger A, Gattringer T, Pinter D.

Wien Med Wochenschr. 2020 Feb;170(1-2):41-54. doi: 10.1007/s10354-019-00707-3. Epub 2019 Sep 18. Review. German.

PMID:
31535230
18.

Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR).

J Neurol. 2019 Nov;266(11):2678. doi: 10.1007/s00415-019-09535-2.

PMID:
31531765
19.

Comment on: External Validation of the PREMISE Score in the Athens Stroke Registry.

Gattringer T, Posekany A, Kiechl S, Fazekas F, Enzinger C.

J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104334. doi: 10.1016/j.jstrokecerebrovasdis.2019.104334. Epub 2019 Aug 20. No abstract available.

PMID:
31444044
20.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
21.

Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR).

J Neurol. 2019 Nov;266(11):2672-2677. doi: 10.1007/s00415-019-09464-0. Epub 2019 Jul 16. Erratum in: J Neurol. 2019 Sep 17;:.

PMID:
31312958
22.

Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.

Kneihsl M, Gattringer T, Bisping E, Scherr D, Raggam R, Mangge H, Enzinger C, Fandler-Höfler S, Eppinger S, Hermetter C, Bucnik B, Poltrum B, Niederkorn K, Fazekas F.

Stroke. 2019 Aug;50(8):2223-2226. doi: 10.1161/STROKEAHA.119.025339. Epub 2019 Jun 20.

PMID:
31216968
23.

Lifespan normative data on rates of brain volume changes.

Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, Filippi M, Rocca MA, Preziosa P, Gallo A, Bisecco A, Palace J, Kong Y, Horakova D, Vaneckova M, Gasperini C, Ruggieri S, De Stefano N; MAGNIMS Study Group.

Neurobiol Aging. 2019 Sep;81:30-37. doi: 10.1016/j.neurobiolaging.2019.05.010. Epub 2019 May 22.

PMID:
31207467
24.

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?

Eppinger S, Gattringer T, Nachbaur L, Fandler S, Pirpamer L, Ropele S, Wardlaw J, Enzinger C, Fazekas F.

Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419835716. doi: 10.1177/1756286419835716. eCollection 2019.

25.

Real-life use of oral disease-modifying treatments in Austria.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR).

Acta Neurol Scand. 2019 Jul;140(1):32-39. doi: 10.1111/ane.13097. Epub 2019 Apr 22.

26.

Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.

d'Ambrosio A, Valsasina P, Gallo A, De Stefano N, Pareto D, Barkhof F, Ciccarelli O, Enzinger C, Tedeschi G, Stromillo ML, Arévalo MJ, Hulst HE, Muhlert N, Koini M, Filippi M, Rocca MA.

Mult Scler. 2019 Mar 19:1352458519837707. doi: 10.1177/1352458519837707. [Epub ahead of print]

PMID:
30887862
27.

Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.

Marini S, Crawford K, Morotti A, Lee MJ, Pezzini A, Moomaw CJ, Flaherty ML, Montaner J, Roquer J, Jimenez-Conde J, Giralt-Steinhauer E, Elosua R, Cuadrado-Godia E, Soriano-Tarraga C, Slowik A, Jagiella JM, Pera J, Urbanik A, Pichler A, Hansen BM, McCauley JL, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Testai FD, Kittner SJ, Schmidt H, Enzinger C, Deary IJ, Rannikmae K, Samarasekera N, Salman RA, Sudlow CL, Klijn CJM, van Nieuwenhuizen KM, Fernandez-Cadenas I, Delgado P, Norrving B, Lindgren A, Goldstein JN, Viswanathan A, Greenberg SM, Falcone GJ, Biffi A, Langefeld CD, Woo D, Rosand J, Anderson CD; International Stroke Genetics Consortium.

JAMA Neurol. 2019 Apr 1;76(4):480-491. doi: 10.1001/jamaneurol.2018.4519.

28.

Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis.

Santangelo G, Altieri M, Enzinger C, Gallo A, Trojano L.

Neuropsychology. 2019 Mar;33(3):379-390. doi: 10.1037/neu0000520. Epub 2019 Jan 31.

PMID:
30702305
29.

Quantitative Susceptibility Mapping to Assess Cerebral Vascular Compliance.

Birkl C, Langkammer C, Sati P, Enzinger C, Fazekas F, Ropele S.

AJNR Am J Neuroradiol. 2019 Mar;40(3):460-463. doi: 10.3174/ajnr.A5933. Epub 2019 Jan 24.

30.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

Lancet Neurol. 2019 Feb;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4. Review.

PMID:
30663609
31.

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.

Chatterjee M, Koel-Simmelink MJ, Verberk IM, Killestein J, Vrenken H, Enzinger C, Ropele S, Fazekas F, Khalil M, Teunissen CE.

Mult Scler J Exp Transl Clin. 2018 Dec 24;4(4):2055217318819535. doi: 10.1177/2055217318819535. eCollection 2018 Oct-Dec.

32.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

33.

Predicting Early Mortality of Acute Ischemic Stroke.

Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, Haring HP, Ferrari J, Lang W, Willeit J, Kiechl S, Enzinger C, Fazekas F; Austrian Stroke Unit Registry Collaborators.

Stroke. 2019 Feb;50(2):349-356. doi: 10.1161/STROKEAHA.118.022863.

PMID:
30580732
34.

Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients.

Pinter D, Enzinger C, Gattringer T, Eppinger S, Niederkorn K, Horner S, Fandler S, Kneihsl M, Krenn K, Bachmaier G, Fazekas F.

Eur J Neurol. 2019 May;26(5):727-732. doi: 10.1111/ene.13879. Epub 2019 Jan 9.

35.

Month-of-birth-effect in multiple sclerosis in Austria.

Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.

Mult Scler. 2019 Dec;25(14):1870-1877. doi: 10.1177/1352458518810924. Epub 2018 Nov 22.

PMID:
30463473
36.

Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature.

Gamperl I, Enzinger C, Pichler A, Feichtinger M, Schlager T, Fertl E.

Clin Case Rep. 2018 Sep 21;6(11):2121-2125. doi: 10.1002/ccr3.1816. eCollection 2018 Nov.

37.

Abnormal Blood Flow on Transcranial Duplex Sonography Predicts Poor Outcome After Stroke Thrombectomy.

Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Horner S, Thaler D, Kraner J, Fandler S, Colonna I, Fazekas F, Gattringer T.

Stroke. 2018 Nov;49(11):2780-2782. doi: 10.1161/STROKEAHA.118.023213.

PMID:
30355211
38.

The effect of disease modifying therapies on CD62L expression in multiple sclerosis.

Voortman MM, Greiner P, Moser D, Stradner MH, Graninger W, Moser A, Haditsch B, Enzinger C, Fuchs S, Fazekas F, Fessler J, Khalil M.

Mult Scler J Exp Transl Clin. 2018 Sep 20;4(3):2055217318800810. doi: 10.1177/2055217318800810. eCollection 2018 Jul-Sep.

39.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

40.

Cerebrovascular disorders.

Fazekas F, Gattringer T, Enzinger C.

Curr Opin Neurol. 2018 Aug;31(4):345-353. doi: 10.1097/WCO.0000000000000566. Review.

PMID:
29878907
41.

Teaching NeuroImages: Convexal subarachnoid hemorrhage accompanied by transient global amnesia.

Beitzke M, Enzinger C, Fazekas F.

Neurology. 2018 May 22;90(21):e1933-e1934. doi: 10.1212/WNL.0000000000005567. No abstract available.

PMID:
29784726
42.

Dysphagia in supratentorial recent small subcortical infarcts results from bilateral pyramidal tract damage.

Fandler S, Gattringer T, Pinter D, Pirpamer L, Borsodi F, Eppinger S, Niederkorn K, Enzinger C, Fazekas F.

Int J Stroke. 2018 Oct;13(8):815-819. doi: 10.1177/1747493018778141. Epub 2018 May 18.

PMID:
29775168
43.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

44.

Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors.

Pinter D, Gattringer T, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, Pichler A, Barro C, Eppinger S, Pirpamer L, Bachmaier G, Ropele S, Wardlaw JM, Kuhle J, Khalil M, Fazekas F.

J Cereb Blood Flow Metab. 2019 Sep;39(9):1669-1677. doi: 10.1177/0271678X18775215. Epub 2018 May 8.

PMID:
29737904
45.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
46.

Stroke Referrals from Nursing Homes: High Rate of Mimics and Late Presentation.

Kneihsl M, Enzinger C, Niederkorn K, Wünsch G, Müller L, Culea V, Lueger A, Fazekas F, Gattringer T.

Cerebrovasc Dis. 2018;45(3-4):109-114. doi: 10.1159/000487813. Epub 2018 Mar 14.

PMID:
29539602
47.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
48.

Grey-matter network disintegration as predictor of cognitive and motor function with aging.

Koini M, Duering M, Gesierich BG, Rombouts SARB, Ropele S, Wagner F, Enzinger C, Schmidt R.

Brain Struct Funct. 2018 Jun;223(5):2475-2487. doi: 10.1007/s00429-018-1642-0. Epub 2018 Mar 6.

49.

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group.

Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Review.

PMID:
29477616
50.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440

Supplemental Content

Loading ...
Support Center